These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 21733800)
41. Risk management frameworks for human health and environmental risks. Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953 [TBL] [Abstract][Full Text] [Related]
42. Gulf oil spill. BP research dollars yield signs of cautious hope. Stokstad E Science; 2013 Feb; 339(6120):636-7. PubMed ID: 23393236 [No Abstract] [Full Text] [Related]
43. Oil spill treatment products approval: the UK approach and potential application to the Gulf region. Kirby MF; Law RJ Mar Pollut Bull; 2008 Jul; 56(7):1243-7. PubMed ID: 18433797 [TBL] [Abstract][Full Text] [Related]
44. Distribution and concentrations of petroleum hydrocarbons associated with the BP/Deepwater Horizon Oil Spill, Gulf of Mexico. Sammarco PW; Kolian SR; Warby RA; Bouldin JL; Subra WA; Porter SA Mar Pollut Bull; 2013 Aug; 73(1):129-43. PubMed ID: 23831318 [TBL] [Abstract][Full Text] [Related]
45. FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment. Roller ST; Pippins RR; Ngai JW Food Drug Law J; 2009; 64(3):577-98. PubMed ID: 19999646 [TBL] [Abstract][Full Text] [Related]
46. Public perceptions of the response to the Deepwater Horizon oil spill: personal experiences, information sources, and social context. Safford TG; Ulrich JD; Hamilton LC J Environ Manage; 2012 Dec; 113():31-9. PubMed ID: 22985712 [TBL] [Abstract][Full Text] [Related]
49. Tasman Spirit oil spill in Pakistan: research response and lessons learned. Janjua NZ; Kadir MM; Lutfi S; Tipre M; Sathiakumar N Am J Ind Med; 2013 Jan; 56(1):124-31. PubMed ID: 22473418 [TBL] [Abstract][Full Text] [Related]
50. Corporate science v the right to know: is the rise of the private sector bringing down a cloak of secrecy? Concar D New Sci; 2002 Mar; 173(2334):14-6. PubMed ID: 12408133 [No Abstract] [Full Text] [Related]
51. A dataset on corporate sustainability disclosure. Tian J; Cheng Q; Xue R; Han Y; Shan Y Sci Data; 2023 Mar; 10(1):182. PubMed ID: 37002227 [TBL] [Abstract][Full Text] [Related]
52. Financial disclosures of scientific papers presented at the 2003 RSNA Annual Meeting: association with reporting of non-Food and Drug Administration-approved uses of industry products. Brown SD; Daly JC; Kalish LA; McDaniel SA Radiology; 2006 Jun; 239(3):849-55. PubMed ID: 16641343 [TBL] [Abstract][Full Text] [Related]
53. Unlocking the corporate documents of British American Tobacco: an invaluable global resource needs radically improved access. Collin J; Lee K; Gilmore AB Lancet; 2004 May; 363(9423):1746-7. PubMed ID: 15172767 [No Abstract] [Full Text] [Related]